The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
about
Colesevelam for type 2 diabetes mellitusColesevelam for type 2 diabetes mellitusThe role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic controlThe blind men 'see' the elephant-the many faces of fatty liver diseaseGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsGut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health?Bile acid receptors and nonalcoholic fatty liver diseaseBile acids: emerging role in management of liver diseasesControversies in the Mechanism of Total Parenteral Nutrition Induced PathologyBile acid metabolism and signalingApples and cardiovascular health--is the gut microbiota a core consideration?Bile acids, obesity, and the metabolic syndromeImpact of hepatitis B virus infection on hepatic metabolic signaling pathwayMechanisms of Body Weight Reduction by Black Tea PolyphenolsBile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver DiseaseBile acid signaling in metabolic disease and drug therapyTranscriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3BFarnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulationFarnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid MetabolismHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverMechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor.Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling.Chemoproteomic Profiling of Bile Acid Interacting ProteinsEffects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.The hepatocyte proteome in organotypic rat liver models and the influence of the local microenvironment.Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease.Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.A comparative study of genome-wide transcriptional profiles of primary hepatocytes in collagen sandwich and monolayer cultures.Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting.Recent advances in the development of farnesoid X receptor agonistsTreatment of dyslipidemia in patients with type 2 diabetes.Endocrine functions of bile acids.Bile acid signaling and liver regeneration.Acetylation and nuclear receptor actionFibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test.Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysisAn updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.
P2860
Q24202334-DAF60364-2594-4B52-B9AA-F50417FD653AQ24236703-9FD040E0-FCD7-4BC5-9E1D-226E0759486EQ24629879-A9F32106-FFE9-4E32-9BAD-8E25B2A40E59Q24654991-C17BEF45-F144-4EFE-95B7-4730EA93B991Q26753047-A09073E6-FF2B-47E4-A166-884E8FB9BCCFQ26765902-359F9ECF-01BB-413B-B2D5-6E96FFC6641FQ26775814-C5559713-DFE9-4F59-84F7-371E119D5315Q26796318-FAD02852-6DE5-4C30-88F7-7C1807EBCE22Q26865276-F65B8F79-9E01-48D8-A07D-4614FD08F6FDQ27002873-E682CBC5-1986-494E-9DDD-770B778356A2Q27011496-6EC3A979-BEDC-41CE-8781-C9E72E4B3E6FQ27020976-F3FC7332-8D7F-47CC-80C5-EDC48811A9E3Q28072127-1D3CF12D-CD64-4B4D-BC6C-3E87DD796D8EQ28072852-FABECD9E-B265-485A-B4B1-25AD52C71359Q28076064-4337BAEF-FFF3-42DC-8306-943E7FE9ED24Q28244875-3EA9D379-4BAB-4369-B787-617D39D6192CQ28247233-81127C11-96AE-4487-84DB-49AC3058E625Q28581627-90A916E7-6518-42CE-BB64-141254C96276Q28821039-75E2612C-4B73-4160-999F-1790D47BD106Q29616840-203F86FE-D9FA-4EE1-87C4-CCC04A868115Q30409833-49446141-F6E1-42D7-ADE8-43C6F76CBB7AQ33610738-255D59F3-058A-445C-A1CE-21906044359FQ33643380-021E9513-2339-45D7-B463-B3FFC9AD84BAQ33731122-2F3DF324-E79A-4F1C-A1E8-FDEC56F7CBE1Q33810241-854FC3DB-6BA9-4902-A639-17ACAC97FD2DQ33823338-8DB67D30-7A8B-4C7E-B9AA-E98135D5AC48Q34019132-375F0C2D-AA41-4786-8521-1A440F43AEB3Q34045391-925EB4D2-AD06-4F3A-9A96-447506249AABQ34079471-7AD99125-7BA8-4E88-948A-F7D3CB516FF5Q34189248-4130071A-47BF-424D-80DF-844676E37430Q34334983-6884ED8D-64DD-4D45-B65B-D624987378A8Q34395323-21CB5F9A-1DC1-4A21-AE65-8492AFB1426EQ34464043-C00D074F-EF72-44D2-93ED-77CC1933371CQ34499472-BA6BA4BB-0C85-4ABC-8FA2-8B452EE76E53Q34545426-4BC800FA-F841-44E9-94FD-30B96C58BC59Q34580008-EDDDD671-F787-43AB-A752-9739A611C1F3Q34666075-FC409701-C44E-4E5C-AF20-F5A49D7BCDA3Q34793530-59BD3414-7C08-4663-A54B-C0BE9D9CC39CQ35104028-66CC8AEA-1714-4A1D-88E3-D83EE92FFDF1Q35206374-8144DBB0-3F18-40EF-88ED-296A8F2F9965
P2860
The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The Farnesoid X receptor: a mo ...... lipid and glucose metabolism.
@ast
The Farnesoid X receptor: a mo ...... lipid and glucose metabolism.
@en
type
label
The Farnesoid X receptor: a mo ...... lipid and glucose metabolism.
@ast
The Farnesoid X receptor: a mo ...... lipid and glucose metabolism.
@en
prefLabel
The Farnesoid X receptor: a mo ...... lipid and glucose metabolism.
@ast
The Farnesoid X receptor: a mo ...... lipid and glucose metabolism.
@en
P1476
The Farnesoid X receptor: a mo ...... lipid and glucose metabolism.
@en
P2093
Folkert Kuipers
Thierry Claudel
P304
P356
10.1161/01.ATV.0000178994.21828.A7
P407
P577
2005-07-21T00:00:00Z